Alexander MJ: Women with co-occurring addictive and mental disorders: an emerging profile of vulnerability. AmJ Orthopsychiatry 66:61-70, 1996 Arndt S, Tyrrell G, Flaum M, et al: Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med 22:379-388, 1992 Barrowclough C, Haddock G, Tarrier N, et al: Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 158:1706-1713, 2001 Barry KL, Fleming MF, GreenleyJR, et al: Characteristics of persons with severe mental illness and substance abuse in rural areas. Psychiatr Serv 47:88-90, 1996

Bennett ME, Bellack AS, Gearon JS: Treating substance abuse in schizophrenia:

an initial report. J Subst Abuse Treat 20:163-175, 2001 Buhler B, Hambrecht M, Loffler W, et al: Precipitation and determination of the onset and course of schizophrenia by substance abuse: a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res 54:243-251, 2002 Cantor-Graae E, Nordstrom LG, McNeil TF: Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 48:69-82, 2001

Caspari D: Cannabis and schizophrenia: results of a follow-up study. Eur Arch Psychiatry Clin Neurosci 249:45-49, 1999 Caton CL, Shrout PE, Eagle PF, et al: Risk factors for homelessness among schizophrenic men: a case-control study, AmJ Public Health 84:265-270, 1994 Chambers RA, Krystal JH, Self DW: A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50:71-83, 2001

Chaperon F, Thiebot MH: Behavioral effects of cannabinoid agents in animals.

Crit Rev Neurobiol 13:243-281, 1999 Comtois KA, Ries R: Sex differences in dually diagnosed severely mentally ill clients in dual diagnosis outpatient treatment. AmJ Addict 4:245-253, 1995 Cuffel BJ, Shumway M, Chouljioa TL, et al: A longitudinal study of substance use and community violence in schizophrenia. J Nerv Ment Dis 182:704-708, 1994

Dassori AM, MezzichJE, Keshavan M: Suicidal indicators in schizophrenia. Acta

Psychiatr Scand 81:409-413, 1990 Davidson S, Judd F, Jolley D, et al: Cardiovascular risk factors for people with mental illness. Aust N Z J Psychiatry 35:196-202, 2001 Dervaux A, Bayle FJ, Laqueille X, et al: Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? Am J Psychiatry 158:492-494, 2001

Dixon L, Haas G, Weiden PJ, et al: Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr Bull 16:6979, 1990

Dixon L, Haas G, Weiden PJ, et al: Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148:224-230, 1991 Drake RE, Osher FC, Wallach MA: Alcohol use and abuse in schizophrenia: a prospective community study. J Nerv Ment Dis 77:408-414, 1989 Drake RE, Osher FC, Wallach MA: Homelessness and dual diagnosis. Am Psychol 46:1149-1158, 1991

Drake RE, Xie H, McHugo GJ, et al: The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull 26:441-449, 2000

Drake RE, Essock SM, Shaner A, et al: Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 52:469-476, 2001 Duke PJ, Pantelis C, Barnes TRE: South Westminster schizophrenia survey: alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. BrJ Psychiatry 164:630-636, 1994 Franklin JE, Frances RF: Alcohol and other psychoactive substance use disorders, in Textbook of Psychiatry, 3rd Edition. Edited by Hales RE, Yudofsky SC, TalbottJA. Washington, DC, American Psychiatric Press, 1999, pp 363-423 Fulwiler C, Grossman H, Forbes C, et al: Early onset substance abuse and community violence by outpatients with chronic mental illness. Psychiatr Serv 48:1181-1185, 1997

Gawin F, Kleber H: Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107-133, 1986 Grassi L, Pavanati M, Cardelli R, et al: HIV-risk behaviour and knowledge about HIV/AIDS among patients with schizophrenia. Psychol Med 29:171-179, 1999 Hambrecht M, Hafner H: Cannabis, vulnerability, and the onset of schizophrenia:

an epidemiological perspective. Aust N Z J Psychiatry 34:468-475, 2000 Hellerstein DJ, Rosenthal RN, Miner CR: Integrating services for schizophrenia and substance abuse. Psychiatr Q 72:291-306, 2001

Holohan N, Dixon L, Drauss N: Outcomes of housing in persons with mental illness and substance use disorders. Poster presented at the 150th annual meeting of the American Psychiatric Association, May 19, 1997, San Diego, CA Hunt GE, Bergen J, Bashir M: Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res 54:253-264, 2002 Jaffe JH: Amphetamine (or amphetamine-like)-related disorders, in Comprehensive Textbook of Psychiatry, 7th Edition. Edited by Sadock BJ, Sadock VA. New York, Lippincott Williams & Wilkins, 1999a, pp 971-981 Jaffe JH: Cocaine-related disorders, in Comprehensive Textbook of Psychiatry, 7th Edition. Edited by Sadock BJ, Sadock VA. New York, Lippincott Williams & Wilkins, 1999b, pp 999-1014 Lambert M, Haasen C, Mass R, et al: [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients] (German). Psychiatr Prax 24:185-189, 1997

Linszen DH, Dingemans PM, Lenior ME: Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 51:273-279, 1994 Littrell KH, Petty RG, Hilligoss NM, et al: Olanzapine treatment for patients with schizophrenia and substance abuse. J Subst Abuse Treat 21:217-221, 2001 McHugo GJ, Drake RE, Teague GB, et al: Fidelity to assertive community treatment and client outcomes in the New Hampshire Dual Diagnosis study. Psychiatr Serv 50:818-824, 1999 Meyer JM: Prevalence of hepatitis A, hepatitis B and HIV among hepatitis C seropositive state hospital patients: results from Oregon State Hospital. J Clin Psychiatry (in press)

Mueser KT, Yarnold PR, Levinson DF, et al: Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 16:31-56, 1990

Mueser KT, Yarnold PR, Bellack AS: Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand 85:48-55, 1992 Mueser KT, Bennett M, Kushner MG: Epidemiology of substance use disorders among persons with chronic mental illness, in Double Jeopardy: Chronic Mental Illness and Substance Use Disorders. Edited by Lehman AF, Dixon LB. Chur, Switzerland, Harwood Academic, 1995, pp 9-26 Mueser KT, Essock SM, Drake RE, et al: Rural and urban differences in patients with a dual diagnosis. Schizophr Res 48:93-107, 2001 Negrete JC, Werner PK, Doublas DE, et al: Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med 16:515-520, 1986 Rasanen P, Tiihonen J, Isohanni M, et al: Schizophrenia, alcohol abuse, and violent behavior: a 26-year follow-up study of an unselected birth cohort. Schizophr Bull 24:437-441, 1998 Regier DA, Farmer ME, Rae DS, et al: Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 264:2511-2518, 1990

Rosenberg SD, Goodman LA, Osher FC, et al: Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 91:31-37, 2001

Salyers MP, Mueser KT: Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr Res 48:109-123, 2001 Scheller-Gilkey G, Lewine RR, Caudle J, et al: Schizophrenia, substance use, and brain morphology. Schizophr Res 35:113-120, 1999 Schuckit MA: Alcohol and alcoholism, in Harrison's Principles of Internal Medicine, 14th Edition. Edited by Fauci AS, Braunwald E, Isselbacher KJ, et al. New York, McGraw-Hill, 1998, pp 2503-2508 Schuckit MA: Alcohol-related disorders, in Comprehensive Textbook of Psychiatry, 7th Edition. Edited by Sadock BJ, Sadock VA. New York, Lippincott Williams & Wilkins, 1999, pp 953-970 Serper MR, Chou JCY, Allen MH, et al: Symptomatic overlap of cocaine intoxication and acute schizophrenia at emergency presentation. Schizophr Bull 25:387-394, 1999

Smelson DA, Losonczy MF, Davis CW, et al: Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry 47:671-675, 2002 Swartz MS, SwansonJW, Hiday VA, et al: Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiatry 155:226-231, 1998

Tashkin D: Airway effects of marijuana, cocaine, and other inhaled illicit agents.

Curr Opin Pulm Med 7:143-161, 2001 Voruganti LNP, Heslegrave RJ, Awad AG: Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. J Nerv Ment Dis 185:463-465, 1997

Woody G, MacFadden W: Cannabis-related disorders, in Substance Abuse: A Comprehensive Textbook, 3rd Edition. Edited by Lowinson J, Ruiz P, Mill-man J, et al. Baltimore, MD, Williams & Wilkins, 1996, pp 810-817 Zimmet SV, Strous RD, Burgess ES, et al: Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. J Clin Psychopharmacol 20:94-98, 2000 Zisook S, Heaton R, Moranville J, et al: Past substance abuse and clinical course of schizophrenia. AmJ Psychiatry 149:552-553, 1992

Defeat Drugs Death

Defeat Drugs Death

This Book Is One Of The Most Valuable Resources In The World When It Comes To Helpful Info On Avoiding And Beating A Fatal Drug Addiction!

Get My Free Ebook

Post a comment